GR80293B - Pharmaceutical composition - Google Patents

Pharmaceutical composition

Info

Publication number
GR80293B
GR80293B GR80293A GR840180293A GR80293B GR 80293 B GR80293 B GR 80293B GR 80293 A GR80293 A GR 80293A GR 840180293 A GR840180293 A GR 840180293A GR 80293 B GR80293 B GR 80293B
Authority
GR
Greece
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
GR80293A
Other languages
English (en)
Inventor
Veda Haruhiko
Toyoda Hidekazu
Fukuda Minoru
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP16435683A external-priority patent/JPS6056921A/ja
Priority claimed from JP15700984A external-priority patent/JPS6136219A/ja
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of GR80293B publication Critical patent/GR80293B/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
GR80293A 1983-09-07 1984-09-05 Pharmaceutical composition GR80293B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP16435683A JPS6056921A (ja) 1983-09-07 1983-09-07 皮膚外用剤
JP15700984A JPS6136219A (ja) 1984-07-27 1984-07-27 皮膚外用剤

Publications (1)

Publication Number Publication Date
GR80293B true GR80293B (en) 1985-01-08

Family

ID=26484601

Family Applications (1)

Application Number Title Priority Date Filing Date
GR80293A GR80293B (en) 1983-09-07 1984-09-05 Pharmaceutical composition

Country Status (6)

Country Link
US (1) US4657901A (el)
EP (1) EP0138029B1 (el)
AU (1) AU570998B2 (el)
DE (1) DE3485408D1 (el)
ES (1) ES8608535A1 (el)
GR (1) GR80293B (el)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5110801A (en) * 1984-08-13 1992-05-05 Leveen Harry H Treatment of acne
US5525635A (en) * 1986-02-04 1996-06-11 Moberg; Sven Pharmaceutical compositions containing propylene glycol and/or polyethylene glycol and urea as active main components and use thereof
SE462139B (sv) * 1986-02-04 1990-05-14 Sven Moberg Farmaceutisk komposition, innehaallande propylenglykol och karbamid, foer behandling av bl.a. nagelsvamp och seborroiskt eksem
CA1340994C (en) * 1989-09-21 2000-05-16 Rudolf Edgar Dr. Falk Treatment of conditions and disease
EP0516026A1 (en) * 1991-05-28 1992-12-02 Takeda Chemical Industries, Ltd. Hydrogel and method of producing same
JP2937667B2 (ja) * 1992-11-19 1999-08-23 高砂香料工業株式会社 尋常性ざ瘡用皮膚外用剤
US5550112A (en) * 1992-12-30 1996-08-27 Patent Biopharmaceutics, Inc. Hyaluronic acid-urea pharmaceutical compositions and uses
US5631242A (en) * 1993-08-04 1997-05-20 Patent Biopharmaceutics, Inc. Hyaluronic acid-urea pharmaceutical compositions utilized for treatment of diseases of cutis
EP0714308A4 (en) * 1993-08-26 1998-07-29 Univ California METHOD, COMPOSITIONS AND DEVICES FOR THE ADMINISTRATION OF NAKED POLYNUCLEOTIDS, WHICH ENCODE FOR BIOLOGICALLY ACTIVE PEPTIDES
US20080213378A1 (en) * 1998-10-01 2008-09-04 Elan Pharma International, Ltd. Nanoparticulate statin formulations and novel statin combinations
US8293277B2 (en) * 1998-10-01 2012-10-23 Alkermes Pharma Ireland Limited Controlled-release nanoparticulate compositions
US20040013613A1 (en) * 2001-05-18 2004-01-22 Jain Rajeev A Rapidly disintegrating solid oral dosage form
EP2266542A3 (en) * 1998-10-01 2013-07-31 Elan Pharma International Limited Controlled release nanoparticulate compositions
US8236352B2 (en) * 1998-10-01 2012-08-07 Alkermes Pharma Ireland Limited Glipizide compositions
US6969529B2 (en) * 2000-09-21 2005-11-29 Elan Pharma International Ltd. Nanoparticulate compositions comprising copolymers of vinyl pyrrolidone and vinyl acetate as surface stabilizers
US20040141925A1 (en) * 1998-11-12 2004-07-22 Elan Pharma International Ltd. Novel triamcinolone compositions
US20040115134A1 (en) * 1999-06-22 2004-06-17 Elan Pharma International Ltd. Novel nifedipine compositions
US20040156872A1 (en) * 2000-05-18 2004-08-12 Elan Pharma International Ltd. Novel nimesulide compositions
US7998507B2 (en) * 2000-09-21 2011-08-16 Elan Pharma International Ltd. Nanoparticulate compositions of mitogen-activated protein (MAP) kinase inhibitors
US7198795B2 (en) * 2000-09-21 2007-04-03 Elan Pharma International Ltd. In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate of nanoparticulate active agent compositions
US20030064084A1 (en) * 2001-09-24 2003-04-03 Bradley Pharmaceuticals, Inc. Novel benzoyl peroxide compositions for the treatment of dermatological disorders and methods for their use
EP1471887B1 (en) * 2002-02-04 2010-04-21 Elan Pharma International Ltd. Nanoparticulate compositions having lysozyme as a surface stabilizer
US20040101566A1 (en) * 2002-02-04 2004-05-27 Elan Pharma International Limited Novel benzoyl peroxide compositions
EP2283864A1 (en) * 2002-07-16 2011-02-16 Elan Pharma International Ltd. Liquid dosage compositions fo stable nanoparticulate active agents
US20050272819A1 (en) * 2003-07-31 2005-12-08 Arye Rubinstein Use of alkylureas for treating acne
GB0505909D0 (en) * 2005-03-23 2005-04-27 Univ Leeds Formulations
FR2900575B1 (fr) * 2006-05-05 2008-10-17 Anteis Sa Gel biocompatible a liberation controlee, son procede de preparation et son utilisation
US20090258865A1 (en) 2008-03-28 2009-10-15 Hale Biopharma Ventures, Llc Administration of benzodiazepine compositions
ES2683902T3 (es) 2011-06-14 2018-09-28 Hale Biopharma Ventures, Llc Administración de benzodiacepina
US10548862B2 (en) * 2017-12-29 2020-02-04 Lester J. Wu Topical formulation and method for preventing or treating acne
JP2024521399A (ja) 2021-06-10 2024-05-31 ニューレリス、インク． 小児患者における発作性障害を治療するための組成物および方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3856829A (en) * 1970-01-07 1974-12-24 Takeda Chemical Industries Ltd 16{62 -hydrocarbon substituted estrane compounds
US4514385A (en) * 1981-10-05 1985-04-30 Alcon Laboratories, Inc. Anti-acne compositions

Also Published As

Publication number Publication date
ES8608535A1 (es) 1986-06-16
AU3243484A (en) 1985-03-14
AU570998B2 (en) 1988-03-31
DE3485408D1 (de) 1992-02-13
US4657901A (en) 1987-04-14
EP0138029B1 (en) 1992-01-02
EP0138029A3 (en) 1988-06-29
ES535711A0 (es) 1986-06-16
EP0138029A2 (en) 1985-04-24

Similar Documents

Publication Publication Date Title
GB2136807B (en) Pharmaceutical compositions
DE3466476D1 (en) External pharmaceutical composition
GB8403668D0 (en) Pharmaceutical compositions
DE3467703D1 (en) Pharmaceutical compositions
GB8313217D0 (en) Pharmaceutical compositions
EP0138029A3 (en) Pharmaceutical composition
GB8325494D0 (en) Pharmaceutical compositions
GB8415975D0 (en) Pharmaceutical compositions
GB8308126D0 (en) Pharmaceutical compositions
GB8325496D0 (en) Pharmaceutical compositions
CY1678A (en) Pharmaceutical compositions
GB2136806B (en) Pharmaceutical compositions
GB8414458D0 (en) Pharmaceutical compositions
CY1503A (en) Pharmaceutical compositions
GB8412569D0 (en) Pharmaceutical compositions
GB8323553D0 (en) Pharmaceutical compositions
GB8417154D0 (en) Pharmaceutical composition
GB8406132D0 (en) Pharmaceutical compositions
EP0136006A3 (en) Pharmaceutical compositions
GB8407735D0 (en) Pharmaceutical composition
GB8300767D0 (en) Pharmaceutical compositions
GB8305697D0 (en) Pharmaceutical compositions
GB8308414D0 (en) Pharmaceutical composition
GB2150435B (en) Pharmaceutical compositions
GB8423725D0 (en) Pharmaceutical composition